JOURNAL 2092
Records of Natural Products
Year: 2023 Issue: 2-March-April
p.280 - 292
Viewed 2685 times.
-
Erdal Sanlidag
-
Eda Becer
-
İhsan Çalış
-
Kemal H. C. Baser
-
Azmi Hanoğlu
-
Fatih Göger
-
H. Seda Vatansever
GRAPHICAL ABSTRACT
ABSTRACT
Amongst all cancer types, liver cancer is the fourth leading cause of cancer mortality. It is frequently stated as hepatocellular carcinoma (HCC) and occurs in hepatocytes. Genetic alterations of hepatocytes such as Wnt/β-catenin and JAK / STAT signaling pathways play a key role for the development of the HCC. Currently, there are a few available treatments for HCC; such treatments include transplantation, surgical resections and anticancer drugs. Most of the anti-cancer drugs target the signaling pathways for achieving an effective treatment. However, these treatments have some undesirable side effects. Thus, there is a need for discovering alternative anti-cancer agents with no or lesser side effects. Plant constituents are promising anti-cancer agents. Cynara cornigera L. contains plenty of phenolic compounds including quercetin, apigenin, etc. This study aimed to analyze the anti-cancer property of the fractionated methanol extract of the flowers of C. cornigera. All the fractions obtained were analyzed to determine the cytotoxic activity on HepG2 cells. Two of the fractions containing polyphenolic compounds had a significant cytotoxic activity related to non-canonical Wnt11 signaling pathways on HepG2 cells.
KEYWORDS- Cynara cornigera
- phenolic compounds
- HepG2
- HepG2
- Wnt11
- liver cancer
